![Silke LEONHARDT | Charité Universitätsmedizin Berlin, Berlin | Charité | Department of Gastroenterology, Infectiology and Rheumatology | Research profile Silke LEONHARDT | Charité Universitätsmedizin Berlin, Berlin | Charité | Department of Gastroenterology, Infectiology and Rheumatology | Research profile](https://www.researchgate.net/publication/286982328/figure/fig1/AS:621173637406728@1525110744778/Course-of-cholestasis-with-typical-sequence-of-GGT-ALP-and-bilirubin-here-in-a_Q320.jpg)
Silke LEONHARDT | Charité Universitätsmedizin Berlin, Berlin | Charité | Department of Gastroenterology, Infectiology and Rheumatology | Research profile
![Silke Leonhardt - Sozialarbeiterin BA – Heilpraktikerin im Bereich der Psychotherapie - Silke Leonhardt | XING Silke Leonhardt - Sozialarbeiterin BA – Heilpraktikerin im Bereich der Psychotherapie - Silke Leonhardt | XING](https://profile-images.xing.com/images/c64fdf1d659b3a12787a61a87338ee3b-4/silke-leonhardt.1024x1024.jpg)
Silke Leonhardt - Sozialarbeiterin BA – Heilpraktikerin im Bereich der Psychotherapie - Silke Leonhardt | XING
![Julia LEONHARDT | Dr., MD | Universitätsklinikum Jena, Jena | Center for Sepsis Control and Care (CSCC) | Research profile Julia LEONHARDT | Dr., MD | Universitätsklinikum Jena, Jena | Center for Sepsis Control and Care (CSCC) | Research profile](https://i1.rgstatic.net/ii/profile.image/1143641833775104-1649676869482_Q512/Julia-Leonhardt.jpg)
Julia LEONHARDT | Dr., MD | Universitätsklinikum Jena, Jena | Center for Sepsis Control and Care (CSCC) | Research profile
![Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients | Hepatology International Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients | Hepatology International](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12072-023-10521-0/MediaObjects/12072_2023_10521_Fig1_HTML.png)
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients | Hepatology International
![Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction - ScienceDirect Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352345X21000175-fx1.jpg)
Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction - ScienceDirect
![Insolvenzordnung (Inso): Amazon.co.uk: Depre, Peter, Fehl, Norbert, Kiesbye, Levke, Leonhardt, Peter, Martin, Marco, Rattunde, Rolf, Rechel, Hans-Peter, Smid, Stefan, Thiemann, Stephan, Wehdeking, Silke, Aghamiri, Bahram, Zeuner, Mark, Leonhardt, Peter ... Insolvenzordnung (Inso): Amazon.co.uk: Depre, Peter, Fehl, Norbert, Kiesbye, Levke, Leonhardt, Peter, Martin, Marco, Rattunde, Rolf, Rechel, Hans-Peter, Smid, Stefan, Thiemann, Stephan, Wehdeking, Silke, Aghamiri, Bahram, Zeuner, Mark, Leonhardt, Peter ...](https://m.media-amazon.com/images/I/61RQ35YTHiL._AC_UF894,1000_QL80_.jpg)
Insolvenzordnung (Inso): Amazon.co.uk: Depre, Peter, Fehl, Norbert, Kiesbye, Levke, Leonhardt, Peter, Martin, Marco, Rattunde, Rolf, Rechel, Hans-Peter, Smid, Stefan, Thiemann, Stephan, Wehdeking, Silke, Aghamiri, Bahram, Zeuner, Mark, Leonhardt, Peter ...
Benjamin Leonhardt on LinkedIn: #littletokyo #duesseldorf #japanesebusiness #japaneseculture #japantage
![FMP spin-off Tubulis acquires €10.7 million for the development of novel antibody drug conjugates (ADCs) FMP spin-off Tubulis acquires €10.7 million for the development of novel antibody drug conjugates (ADCs)](https://leibniz-fmp.de/fileadmin/Data/Images/Press_releases_2022/tubulis_group_Heinrich_Leonhardt__Jonas_Helma__Dominik_Schumacher_und_Christian_Hackenberger_Fotografi_n_Carolin_Bleese.jpg)